Kinase Inhibitor Pulldown Assay (KiP) for Clinical Proteomics
A. B. Saltzman, D. Chan, M. V. Holt, J. Wang, E. J. Jaehnig, M. Anurag, P. Singh, A. Malovannaya, B.-J. Kim, M. J. Ellis
The paper introduces a kinase inhibitor pulldown assay (KiP) combined with PRM for clinical proteomics, improving kinase quantification in cancer samples.
bioRxiv · Oct 13, 2022Biochemistry